» Articles » PMID: 38215548

The Human Vaginal Microbiota: from Clinical Medicine to Models to Mechanisms

Overview
Specialty Microbiology
Date 2024 Jan 12
PMID 38215548
Authors
Affiliations
Soon will be listed here.
Abstract

The composition of the vaginal microbiota is linked to numerous reproductive health problems, including increased susceptibility to infection, pregnancy complications, and impaired vaginal tissue repair; however, the mechanisms contributing to these adverse outcomes are not yet fully defined. In this review, we highlight recent clinical advancements associating vaginal microbiome composition and function with health outcomes. Subsequently, we provide a summary of emerging models employed to identify microbe-microbe interactions contributing to vaginal health, including metagenomic sequencing, multi-omics approaches, and advances in vaginal microbiota cultivation. Last, we review new in vitro, ex vivo, and in vivo models, such as organoids and humanized microbiota murine models, used to define and mechanistically explore host-microbe interactions at the vaginal mucosa.

Citing Articles

The Urogenital System Microbiota: Is It a New Gamechanger in Urogenital Cancers?.

Ece G, Aktas A, Caner A, Saglik I, Kula Atik T, Ulusan Bagci O Microorganisms. 2025; 13(2).

PMID: 40005682 PMC: 11858393. DOI: 10.3390/microorganisms13020315.


Unlocking Cardioprotective Potential of Gut Microbiome: Exploring Therapeutic Strategies.

Qu J, Meng F, Wang Z, Xu W J Microbiol Biotechnol. 2024; 34(12):2413-2424.

PMID: 39467697 PMC: 11729380. DOI: 10.4014/jmb.2405.05019.


Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections.

Avitabile E, Menotti L, Croatti V, Giordani B, Parolin C, Vitali B Int J Mol Sci. 2024; 25(17).

PMID: 39273118 PMC: 11395631. DOI: 10.3390/ijms25179168.


Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models.

Avitabile E, Menotti L, Giordani B, Croatti V, Parolin C, Vitali B Int J Mol Sci. 2024; 25(5).

PMID: 38473739 PMC: 10931810. DOI: 10.3390/ijms25052492.

References
1.
Schwebke J, Carter B, Waldbaum A, Agnew K, Paull J, Price C . A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol X. 2021; 10:100121. PMC: 7843408. DOI: 10.1016/j.eurox.2021.100121. View

2.
Mehta S, Nannini D, Otieno F, Green S, Agingu W, Landay A . Host Genetic Factors Associated with Vaginal Microbiome Composition in Kenyan Women. mSystems. 2020; 5(4). PMC: 7394359. DOI: 10.1128/mSystems.00502-20. View

3.
Johnston W, Ware A, Kuiters W, Delaney C, Brown J, Hagen S . bacterial vaginosis biofilm community manipulation using endolysin therapy. Biofilm. 2023; 5:100101. PMC: 9841237. DOI: 10.1016/j.bioflm.2022.100101. View

4.
Borgogna J, Shardell M, Santori E, Nelson T, Rath J, Glover E . The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis. BJOG. 2019; 127(2):182-192. PMC: 6982399. DOI: 10.1111/1471-0528.15981. View

5.
Auchtung J, Preisner E, Collins J, Lerma A, Britton R . Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction. mSphere. 2020; 5(4). PMC: 7392540. DOI: 10.1128/mSphere.00387-20. View